The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of bevacizumab plus trifluridine/tipiracil and irinotecan as second-line therapy for RAS wild-type metastatic colorectal cancer.
 
Wenju Chen
No Relationships to Disclose
 
Jiayu Niu
No Relationships to Disclose
 
Shusheng Wu
No Relationships to Disclose
 
Huijun Xu
No Relationships to Disclose
 
Lulu Cao
No Relationships to Disclose
 
Mengge Li
No Relationships to Disclose
 
Huiqin Luo
No Relationships to Disclose
 
Lihong Ke
No Relationships to Disclose
 
Ying Yan
No Relationships to Disclose
 
Gang Wang
No Relationships to Disclose
 
Yifu He
No Relationships to Disclose